CAS: 2381037-82-5
RBN-2397
CAS:2381037-82-5
RBN-2397 is a potent, selective and orally active accross species NAD+ competitive PARP7 inhibitor with …
Formula:
C20H23F6N7O3
Purity:
99.96%
Color and Shape:
Solid
Molecular weight:
523.43
Ref: TM-T12695
1mg | 162.00 € | |
5mg | 386.00 € | |
10mg | 574.00 € | |
25mg | 919.00 € | |
50mg | 1,236.00 € | |
100mg | 1,663.00 € | |
500mg | 3,344.00 € | |
1ml*10 (DMSO) | 424.00 € |
Estimated delivery in United States, on Friday 10 May 2024
5-[[(1S)-1-methyl-2-[3-oxo-3-[4-[5-(trifluoromethyl)-2-pyrimidinyl]-1-piperazinyl]propoxy]ethyl]amino]-4-(trifluoromethyl)-3(2H)-pyridazinone
CAS:2381037-82-5
Formula:
C20H23F6N7O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
523.4321
Ref: AN-AG01KBK1
1mg | 56.00 € | |
5mg | 90.00 € | |
10mg | 125.00 € | |
25mg | 145.00 € | |
50mg | 242.00 € | |
100mg | 544.00 € | |
250mg | To inquire |
Estimated delivery in United States, on Friday 10 May 2024
RBN-2397
CAS:2381037-82-5
RBN-2397 is a poly-adp-ribose polymerase inhibitor that has been shown to have clinical efficacy in …
Formula:
C20H23F6N7O3
Purity:
Min. 95%
Molecular weight:
523.4 g/mol
Ref: 3D-GVD03782
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Estimated delivery in United States, on Friday 21 Jun 2024